Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Geoffrey Oxnard, MD, Dana-Farber Cancer Institute, Boston, MA, outlines how useful cell-free DNA sequencing will be in the clinical setting at the European Society for Medical Oncology (ESMO) 2019 congress in Barcelona, Spain.